Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TAUG - Tauriga to resume clinical work for pharmaceutical-grade Tauri-Gum


TAUG - Tauriga to resume clinical work for pharmaceutical-grade Tauri-Gum

Tauriga Sciences (TAUG) announces the resumption of clinical development for its proposed “Anti-Nausea” pharmaceutical-grade version of Tauri-Gum™. The company, focused on the Cannabidiol and Cannabigerol Edibles market, filed a provisional U.S. patent in March covering the pharmaceutical-grade version of Tauri-Gum™.Tauriga calls the delivery system for the proposed product as a ’modified version (substantially higher concentration of CBD) of the existing “Tauri-Gum™” chewing gum formulation’.In addition to the clinical development of Tauri-Gum™, the company has collaborated with Aegea Biotechnologies to develop a rapid, multiplexed, Novel Coronavirus (COVID-19) test.

For further details see:

Tauriga to resume clinical work for pharmaceutical-grade Tauri-Gum
Stock Information

Company Name: Tauriga Sciences Inc
Stock Symbol: TAUG
Market: OTC
Website: tauriga.com

Menu

TAUG TAUG Quote TAUG Short TAUG News TAUG Articles TAUG Message Board
Get TAUG Alerts

News, Short Squeeze, Breakout and More Instantly...